Catalyst Wire Dossier Catalyst Wire Dossier

Halneuron

· Dogwood Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Halneuron, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain [Phase 2]

See pricing